In addition to its role as an immunomodulatory cytokine, IL-6 acts as an autocrine and paracrine growth factor [74] and has been reported to be involved in prostate cancer cell growth by activating signaling pathways/signal transducers and activators of transcription factors, including the STAT family [75,76,77]. Here, IL6 is linked to prostate carcinoma.